Terms: = Prostate cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Diagnosis
7 results:
1. PI-RADS
Yu R; Jiang KW; Bao J; Hou Y; Yi Y; Wu D; Song Y; Hu CH; Yang G; Zhang YD
Br J Cancer; 2023 Apr; 128(6):1019-1029. PubMed ID: 36599915
[TBL] [Abstract] [Full Text] [Related]
2. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
Beltran H; Romanel A; Conteduca V; Casiraghi N; Sigouros M; Franceschini GM; Orlando F; Fedrizzi T; Ku SY; Dann E; Alonso A; Mosquera JM; Sboner A; Xiang J; Elemento O; Nanus DM; Tagawa ST; Benelli M; Demichelis F
J Clin Invest; 2020 Apr; 130(4):1653-1668. PubMed ID: 32091413
[TBL] [Abstract] [Full Text] [Related]
3. High-Frequency Quantitative Ultrasound for Imaging prostate cancer Using a Novel Micro-Ultrasound Scanner.
Rohrbach D; Wodlinger B; Wen J; Mamou J; Feleppa E
Ultrasound Med Biol; 2018 Jul; 44(7):1341-1354. PubMed ID: 29627083
[TBL] [Abstract] [Full Text] [Related]
4. The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study.
Xin JY; Gao SS; Liu JG; Sun CF; Han Y; Sun XH; Wang XZ; Wang B
Magn Reson Imaging; 2017 Dec; 44():26-31. PubMed ID: 28782677
[TBL] [Abstract] [Full Text] [Related]
5. Deubiquitinases and the new therapeutic opportunities offered to cancer.
Pfoh R; Lacdao IK; Saridakis V
Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
[TBL] [Abstract] [Full Text] [Related]
6. A rare case of solitary metastatic non-seminomatous malignant germ cell tumor to the prostate.
Dobbs RW; Osunkoya AO; Nieh PT; Canter DJ
Can J Urol; 2012 Oct; 19(5):6471-3. PubMed ID: 23040630
[TBL] [Abstract] [Full Text] [Related]
7. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database.
Cooper SC; Trudgill NJ
Cancer Causes Control; 2012 Jun; 23(6):819-25. PubMed ID: 24251326
[TBL] [Abstract] [Full Text] [Related]
